Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03997851 · ClinicalTrials.gov registry record · Phase 1
Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03997851 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 17 participants.
The verdict
NCT03997851, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
Currently, topical antihistamines and corticosteroids are mainly used for itching relief. However, the over the counter antihistamines are not effective on all itch conditions. Acetaminophen is a popular and widely used OTC drug for pain relief. Although its mode of action is still unknown, recent studies have shown that acetaminophen indirectly activates cannabinoid CB1 receptors. Recent studies have shown that topical cannabinoid agonists are effective for itch relief, the efficacy of topical acetaminophen will be tested for non-histaminergic itch relief.
Interventions
- DRUG Acetaminophen
- DRUG Carbomer 980
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2020-03-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03997851
The ClinicalTrials.gov registry entry for NCT03997851 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03997851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03997851 about?
NCT03997851 is a clinical study titled "Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects". Currently, topical antihistamines and corticosteroids are mainly used for itching relief. However, the over the counter antihistamines are not effective on all itch conditions. Acetaminophen is a popular and widely used OTC drug for pain relief. Although its mode of action is still unknown, recent s...
What is the current status of trial NCT03997851?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2019-07-22. Estimated completion is 2020-03-18.
What interventions are being tested in trial NCT03997851?
The interventions under investigation include: Acetaminophen (DRUG), Carbomer 980 (DRUG).
Who is sponsoring clinical trial NCT03997851?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.